1. Johnson & Johnson: – Resuming the use of Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be...
Read More